NORTHWESTERN MEDICINE EXPERTS AT THE
​AHA SCIENTIFIC SESSIONS 2024

The American Heart Association Scientific Sessions 2024 was held from November 16 through 18 at McCormick Place Convention Center in Chicago, Illinois.

Cardiologists, cardiac surgeons and experts in cardiovascular disease and stroke had the opportunity to engage with other experts and expand their knowledge. This event served as a platform for presenting and discussing the leading-edge research, advances in cardiovascular science and clinical breakthroughs.
​
Several Northwestern Medicine cardiovascular physicians were among the many speakers and presenters sharing research, new findings and the latest advances. ​See the Northwestern Medicine physicians who presented at AHA.24 below.

​We also invite you to take a look at an interview taken at this year's meeting featuring Clyde Yancy, MD, MSc, professor and chief of Cardiology at Northwestern Medicine and a former AHA president, as he spoke with Cardiovascular Business about the excitement in cardiology over the new treatment options available for patients with heart failure with preserved ejection fraction (HFpEF).

NORTHWESTERN MEDICINE PRESENTATION HIGHLIGHTS

Date
​Time
Location
Session
Presenter
Friday, November 15
8:35 – 8:45 am
S102D
Bridging Research and Health Systems for Smarter Implementation
​Faraz S. Ahmad, MD, MS
                              ​3:00 – 3:07 pm​
​S105ABC
​The JCI
Elizabeth M. McNally, MD, PhD
3:21 – 3:28 pm
S105ABC
​JAMA Cardiology
Robert O. Bonow, MD
​
5:00 – 6:00 pm
S105D
An Introduction to Clinical Cardiovascular Genetic Testing Best Practices: A Flipped Classroom-Style Session (GPM)
Lisa D. Wilsbacher, MD, PhD
​
5:12 – 5:24 pm
S104B
Discuss Strategies for Dissemination and Implementation of Findings Into Real-World Settings to Improve Cardiometabolic Health for All
Clyde W. Yancy, MD, MSc
Saturday, November 16
9:52 – 9:59 am
​N230B
Serum Biomarkers of Cardiac Stress and Heart Failure Prevention: Where are the Gaps?
Sadiya S. Khan, MD, MSc
9:57 – 10:09 am
N230A
Is PREVENT Accurate for Asian People?
Nilay S. Shah, MD, MPH
​
​10:30 – 11:30 am      
​Zone 4
​The Heart of the Matter: The Interplay Between Cardiovascular Disease and Cancer
​Nausheen Akhter, MD
10:30 – 11:30 am      
​Zone 2
​Cool Clinical Cases in Heart Failure
​Sarah E. Chuzi, MD
​10:30 – 11:30 am     
​Zone 3
​Medley of Cardiovascular Risk Factors, Stratification, and Prediction
​Nilay S. Shah, MD, MPH
​1:30 – 2:45 pm         
​S103A
​Genomic and Precision Medicine Early Career Investigator Award Competition
Lisa D. Wilsbacher, MD, PhD
1:30 – 2:45 pm
S101A
(Panelist) Getting All Patients the Vascular Care Warranted-actionable Approaches Towards Dissolving Disparities in Peripheral Vascular Disease
Karen J. Ho, MD
​
1:40 – 1:50 pm
N226
Multisystem Pathology of HFpEF in Obesity
Sanjiv J. Shah, MD
​
​1:50 – 1:55 pm         
​Zone 2‚ Moderated Digital Poster 10
​High-Intensity Walking Exercise Minutes and Improved Walking Performance in Peripheral Artery Disease: LITE Randomized Clinical Trial
​Neela Thangada, MD
2:00 – 2:15 pm
N138
nuMoM2b Heart Health Study: Findings and Ongoing Data Collection
Sadiya S. Khan, MD, MSc
​
​2:00 – 3:00 pm         
​Zone 2
​Cardiomyopathy Potpourri 1
Ike S. Okwuosa, MD
3:15 – 4:30 pm
Main Event II
Fellowship of the Ring: Atrial Fibrillation & Heart Failure, A Collaborative Journey Through the New Middle Earth
Quentin R. Youmans, MD, MSc
​
3:35 – 3:45 pm
​S105ABC
Genetic Testing and Interpretation for Inherited Cardiovascular Diseases in Underrepresented Populations
 Lisa D. Wilsbacher, MD, PhD
Sunday, November 17
​8:00 – 9:15 am
​S106B
​Patterns and Cardiovascular Consequences of Progressive Cardiometabolic Disease
​Sadiya S. Khan, MD, MSc
8:00 – 9:15 am        
N137
Becoming a Cardiovascular Physician-Scientist and Mastering Scientific Writing
Elizabeth M. McNally, MD, PhD, and Donald M. Lloyd-Jones, MD, ScM
​10:00 – 10:05 am     
​Zone 1‚ Moderated Digital Poster 1
​NOX2-generated oxidative stress in the epicardial adipose tissue promotes left atrial electrical remodeling in a canine model of atrial fibrillation
Anna Pfenniger, MD, PhD
​10:55 – 11:00 am     
​N140
​Too Far Gone? Revascularization of Multivessel CAD in Severe Cardiomyopathy
Paul C. Cremer, MD
​11:10 – 12:35 pm    
​Zone 2‚ Moderated Digital Poster 6
​Tomorrow's Solutions Today: Discovery Science in Vascular Disease
​Karen J. Ho, MD
​11:20 – 11:25 am     
​Zone 3‚ Moderated Digital Poster 12
​Heart Failure Quality of Care and Outcomes among Asian Ethnic Groups in the United States
Nilay S. Shah, MD, MPH
3:30 – 4:45 pm      ​
N140
Bringing Surveillance Data Back to the Community: Data Resources and Modernization
Nilay S. Shah, MD, MPH​
​3:30 – 4:45 pm         
​N230A
​Atrial Fibrillation and Stroke: From Wearables and Implantables to Prevention and Outcomes - CRYSTAL Clear or Clear as Mud?
​Rod S. Passman, MD
3:42 – 3:54 pm
S103BC
Gene Therapy for Rare Cardiovascular Diseases
Elizabeth M. McNally, MD, PhD
​
Monday, November 18
​8:00 – 8:10 am
Main Event I
​Myeloperoxidase Inhibition with Mitiperstat in Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Primary Results from the ENDEAVOR Randomized Clinical Trial
​Sanjiv J. Shah, MD
​8:00 – 9:15 am          
   ​ Main Event I
​Building on the 4 Pillars: Novel Trials of Medical Therapy for Heart Failure
​Jane E. Wilcox, MD, MSc, and Ravi B. Patel, MD, MSc
10:00 – 10:12 am     
      S106B
Myosin Binding Protein C As a Target for Hypertrophic Cardiomyopathy
Elizabeth M. McNally, MD, PhD
​
​10:00 – 10:15 am      
​S104B
​Amyloidosis Awareness: Closing the Gap in Diagnosis and Treatment Access
​Ike S. Okwuosa, MD
​10:15 – 10:30 am     
​N228
​PREVENT Algorithm
​Sadiya S. Khan, MD, MSc
​11:10 – 12:35 pm      
​Zone 2‚ Moderated Digital Poster 7
​Risky Business: What We Know and Don't Know about Cardiovascular Health in Cancer Survivors
Anjali Rao, MD
​12:50 – 2:15 pm         
​Zone 1‚ Moderated Digital Poster 3
​Cardiovascular Imaging
​Paul C. Cremer, MD
1:30 – 1:40 pm
S101A
​
The Nuts and Bolt of the PREVENT Risk Model
Sadiya S. Khan, MD, MSc
​
1:30 – 1:45 pm
Main Event II
Gene Therapy in the Cardiology Clinic: Ready for Prime Time?
Elizabeth M. McNally, MD, PhD
​
​1:30 – 2:30 pm        
​Zone 4
​Ace of MACE: Major Adverse Cardiovascular Events in Cardio-Oncology
Anjali Rao, MD
1:50 – 2:00 pm
S101A​
Cardiovascular Health, CKM Syndrome, and CVD Risk Prediction: Putting It All Together​
Donald M. Lloyd-Jones, MD, ScM

follow northwestern medicine Cardiovascular